Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

KETAMINE HAMELN INJECTION 50 MG/ML

Approval Number

SIN15402P

Drug Name

KETAMINE HAMELN INJECTION 50 MG/ML

Product Name

KETAMINE HAMELN INJECTION 50 MG/ML

Approval Date

January 9, 2018

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Regulatory Information

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS, INTRAMUSCULAR

Medical Information

ATC Code

N01AX03

ATC Item Name

ketamine

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS PHARMA PTE. LTD.

Manufacturers

Siegfried Hameln GmbH

Active Ingredients

Ingredient Name

Ketamine hydrochloride 57.7 mg/ml eqv to Ketamine 50mg/ml

Strength

50 MG

Drug MonographKetamine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

KETAMINE HAMELN INJECTION 50 MG/ML - HSA Approval | MedPath